Thierry Bonnaud

This inventor holds 14 USPTO granted patents and 19 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Neurocrine Biosciences, Inc., Mycovia Pharmaceuticals, Inc., Spero Therapeutics, Inc.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thierry Bonnaud. Retrieved from https://idiyas.com/inventor/thierry-bonnaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 19)

% Patents Active = 92.9

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 41(Granted Patents)

Location History:

Essex, GB (2011)
Cambridge, MA (US) (2021)
Cambridge, GB (2013 - 2023)

Company Filing History:

4 out of 123

Neurocrine Biosciences, Inc.

patents

3 out of 21

Mycovia Pharmaceuticals, Inc.

patents

3 out of 8

Spero Therapeutics, Inc.

Viamet Pharmaceuticals, Inc.

patents

Years Active: 2011-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098155 - Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use (2024-09-24),

2. 11718621 - Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use (2023-08-08),

3. 11149039 - Process for preparing spiro derivatives (2021-10-19),

4. 10889587 - Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use (2021-01-12),

5. 10851104 - Valbenazine salts and polymorphs thereof (2020-12-01),

6. 10851103 - Valbenazine salts and polymorphs thereof (2020-12-01),

7. 10844058 - Valbenazine salts and polymorphs thereof (2020-11-24),

8. 10676459 - Antifungal compounds and processes for making (2020-06-09),

9. 10414751 - Antifungal compounds and processes for making (2019-09-17),

10. 10370353 - Antifungal compounds and processes for making (2019-08-06),

11. 10065952 - Valbenazine salts and polymorphs thereof (2018-09-04),

12. 9840492 - Antifungal compounds and processes for making (2017-12-12),

13. 8536196 - Substituted 1,3-dioxanes useful as PPAR modulators (2013-09-17),

14. 7915300 - Cysteine protease inhibitors (2011-03-29),

Title: Innovator Spotlight: Thierry Bonnaud's Contributions to Pharmaceutical Innovations

Introduction:

Thierry Bonnaud, a distinguished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceutical innovations. With a notable track record of 14 patents to his name, Bonnaud continues to push the boundaries of scientific discovery in the realm of antibiotic-resistant bacterial infections.

Latest Patents:

One of Bonnaud's recent patents involves Tebipenem pivoxil crystalline forms, compositions, and methods of use. This groundbreaking patent introduces new crystalline salt forms of tebipenem pivoxil, offering innovative solutions for treating antibiotic-resistant bacterial infections. The patent encompasses various salt forms, including ethane sulfonate, ketoglutarate, maleate, malate, methane sulfonate, hydrobromide, and edisylate, each designed to enhance efficacy in combatting bacterial infections.

Career Highlights:

Throughout his career, Bonnaud has demonstrated a strong commitment to advancing pharmaceutical research. He has been associated with esteemed companies such as Neurocrine Biosciences, Inc. and Mycovia Pharmaceuticals, Inc., where he has played a pivotal role in developing cutting-edge medications to address critical medical needs. Bonnaud's expertise in pharmacology and drug development has solidified his standing as a leading figure in the pharmaceutical industry.

Collaborations:

Collaboration plays a key role in Bonnaud's innovative endeavors. Working closely with accomplished colleagues like Andrew Carr and Kevin McGee, Bonnaud has fostered a collaborative environment conducive to groundbreaking discoveries. By leveraging the diverse skill sets and perspectives of his coworkers, Bonnaud has been able to explore new avenues of research and drive impactful innovations in the pharmaceutical landscape.

Conclusion:

In conclusion, Thierry Bonnaud stands out as a visionary inventor with a passion for developing novel solutions to combat antibiotic-resistant bacterial infections. His extensive patent portfolio and successful industry collaborations underscore his invaluable contributions to the field of pharmaceutical innovations. Bonnaud's relentless pursuit of scientific excellence continues to inspire progress and innovation in the quest for improved healthcare solutions.

Profile summary based on public USPTO records.